Trevi Therapeutics, Inc. (TRVI)
16.64
-0.18
(-1.10%)
USD |
NASDAQ |
Sep 09, 16:00
16.64
0.00 (0.00%)
After-Hours: 16:07
Trevi Therapeutics Total Liabilities (Quarterly) : 9.012M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.012M |
| March 31, 2026 | 7.479M |
| December 31, 2025 | 10.38M |
| September 30, 2025 | 9.568M |
| June 30, 2025 | 9.846M |
| March 31, 2025 | 7.547M |
| December 31, 2024 | 11.26M |
| September 30, 2024 | 9.939M |
| June 30, 2024 | 7.636M |
| March 31, 2024 | 6.225M |
| December 31, 2023 | 6.856M |
| September 30, 2023 | 6.286M |
| June 30, 2023 | 5.904M |
| March 31, 2023 | 14.47M |
| December 31, 2022 | 15.56M |
| September 30, 2022 | 18.46M |
| June 30, 2022 | 20.90M |
| March 31, 2022 | 19.92M |
| Date | Value |
|---|---|
| December 31, 2021 | 21.40M |
| September 30, 2021 | 20.22M |
| June 30, 2021 | 21.41M |
| March 31, 2021 | 19.18M |
| December 31, 2020 | 19.85M |
| September 30, 2020 | 20.26M |
| June 30, 2020 | 6.972M |
| March 31, 2020 | 7.436M |
| December 31, 2019 | 5.456M |
| September 30, 2019 | 5.313M |
| June 30, 2019 | 7.413M |
| March 31, 2019 | 4.51M |
| December 31, 2018 | 4.278M |
| September 30, 2018 | 3.338M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 7.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 330.52M |
| Shareholders Equity (Quarterly) | 321.51M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 37.28 |
| Net Debt Paydown Yield | 0.00% |